Noveome Biotherapeutics Stock

Noveome Biotherapeutics focuses on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.

Sign up today and learn more about Noveome Biotherapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Noveome Biotherapeutics Stock

Noveome Biotherapeutics is a clinical-stage company focusing on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company's products contain a variety of biologic components at physiological concentrations that work together and synergistically to produce anti-inflammatory, neuroprotective, anti-apoptotic, and vascular integrity preservative properties.

Funding History

July 2012$571K
April 2016$2.2M
April 2019$15.0M
May 2020$4.0M
October 2020$870K
August 2023$20.7M

Management

Executive VP of Medical Affairs, Chief Medical Officer

David Steed

Executive Vice President and Chief Scientific Officer

Larry Brown

Board Member

Christopher J. P. Velis

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo